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Abstract
Background: The aim of the study was to evaluate QRS duration and axis as predictors of response to 
cardiac resynchronization therapy (CRT) in order to reduce the proportion of non-responders.
Methods: Retrospective single-center study including 42 CRT recipients, with left bundle branch block 
(LBBB), left ventricular ejection fraction (LVEF) < 40%, in New York Heart Association (NYHA) 
class ≥ II. Response to CRT was declared as NYHA class improvement ≥ 1 (symptomatic) and LVEF 
improvement by ≥ 10% (echocardiographic) > 6 months post implantation.
Results: Symptomatic responders had longer pre- (172.3 ± 17.9 vs. 159.0 ± 18.3 ms; p = 0.027) and 
postimplantation (157.2 ± 24.1 vs. 136.7 ± 23.2 ms; p = 0.009) QRS duration. Preimplantation QRS 
< 150 ms predicted poor response (odds ratio [OR] for response vs. lack of response 0.04; 95% confi-
dence interval [CI] 0.001–0.74). Predictors of symptomatic response included: postimplantation QRS > 
160 ms (OR 7.2; 95% CI 1.24–41.94), longer QRS duration before (OR for a 1 ms increase 1.04, 95% 
CI 1.00–1.08) and post implantation (OR for a 1 ms increase 1.04; 95% CI 1.01–1.07). Area under the 
curve (AUC) for pre- and postimplantation QRS duration was 0.672 (95% CI 0.51–0.84) and 0.727 
(95% CI 0.57–0.89), respectively, with cut-off points of 178.5 ms and 157 ms. For post implantation 
QRS axis, AUC was 0.689 (95% CI 0.53–0.85), with cut-off points of –60.5° or –38.5°. Preimplanta-
tion QRS axis was the only predictor of echocardiographic response (OR 0.98; 95% CI 0.96–1.00), with 
AUC of 0.693 (95% CI 0.54–0.85) and a threshold of –36°.
Conclusions: Marked pre- and postimplantation QRS prolongation and preimplantation negative 
QRS axis deviation are moderate predictors of response to CRT. (Cardiol J XXX; XX, X: xx–xx)
Key words: cardiac resynchronization therapy, heart failure, left bundle branch block, 
QRS axis
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Introduction
Cardiac resynchronization therapy (CRT) is 
a well-proven beneficial treatment strategy for 
patients with chronic heart failure and reduced 
left ventricular ejection fraction (HF-rEF), and 
prolonged QRS duration [1]. Large studies have 
demonstrated that this therapeutic option not only 
reduces mortality and morbidity, but also improves 
symptoms and quality of life [2–4]. However, a 
significant proportion of patients treated with CRT 
do not achieve the desired response, emphasizing 
the need for better selection criteria [5]. Previous 
studies have recognized some simple electrocar-
diographic parameters, such as QRS morphology, 
duration and axis, as predictors of response to CRT 
[6–8]. However, the data are still sparse and incon-
clusive, particularly with regard to the predictive 
role of QRS axis in CRT candidates, and no thresh-
old values for QRS axis have been established so 
far regarding positive response to CRT.
Thus, the aim of this study was to evaluate 
the potential usefulness of QRS duration and QRS 
axis orientation in predicting symptomatic (SR) and 
echocardiographic response (ER) to CRT in HF-rEF 
patients with left bundle branch block (LBBB).
Methods
Study design and patients
The study is a retrospective single-arm, 
single-center analysis including Caucasian pa-
tients implanted with cardiac resynchronization 
therapy-defibrillators (CRT-D) at the Department 
of Cardiology and Internal Medicine, Dr. A. Jurasz 
University Hospital No. 1 in Bydgoszcz from July 
2010 through April 2016. All study participants 
were adults (> 18 years of age) with QRS duration 
> 120 ms, LBBB QRS morphology, left ventricular 
ejection fraction (LVEF) < 40%, and functional 
capacity of at least class II according to the New 
York Heart Association (NYHA) functional clas-
sification. Various transvenous delivery systems, 
left ventricle (LV) leads, and CRT-D devices from 
different companies were used. The most frequent 
target for LV lead placement was the postero-
lateral aspect of the LV. Apical positions were 
avoided. All LV leads were implanted intravenously. 
The VV interval was set between –20 and 0 ms, 
and the atrio-ventricular (AV) interval between 
100–120 ms for sensed and 140–160 ms for paced 
atrial events. Presence of anodal LV pacing was ex-
cluded through programming LV pacing to bipolar 
or by confirmation of the presence of biventricular 
pacing morphology on electrocardiogram (ECG) 
in case of other configurations of LV pacing. No 
echocardiographic optimization of the device set-
tings after implantation was implemented. LVEF 
was calculated by experienced echocardiographers 
using the modified Simpson rule. Pharmacotherapy 
in study participants was in line with the recom-
mendations of the European Society of Cardiology. 
Patients undergoing an upgrade of conventional de-
vices to CRT or a CRT replacement and those with 
incomplete data regarding electrocardiographic or 
echocardiographic parameters were excluded. All 
data were extracted from discharge cards, echocar-
diography and electrocardiography examinations. 
The study protocol was approved by the Bioethics 
Committee of the Nicolaus Copernicus University 
in Torun (Poland).
Electrocardiograms
A standard 12-lead ECG was recorded at a 
speed of 25 mm/s during the index hospitalization 
before and after the implantation procedure. Visual 
assessment of ECG recordings was performed by 
two independent researchers. The QRS duration 
was measured with a manual caliper in all 12 leads 
and the highest result was considered for further 
analysis. The preimplantation QRS duration was 
divided into three groups: < 150, 150–199, and 
≥ 200 ms [6]. Similarly, postimplantation QRS 
duration was classified into three groups (< 120, 
120–160, and > 160 ms) [6]. QRS axis was meas-
ured in leads I, II and aVF according to the method 
described in the literature [9]. QRS axis both as a 
quantitative value (expressed in degrees) and a 
qualitative category are presented. Normal axis 
was defined for values ranging between +90° and 
–30°, right axis deviation (RAD) for values between 
+90° and 180°, left axis deviation (LAD) for values 
between –30° and –90° and extreme axis deviation 
(EAD) for values between –90° and 180°. LBBB 
was diagnosed according to Polish Cardiac Society 
recommendations as: QRS duration ≥ 120 ms, with 
broad, slurred R-wave or R-wave with plateau at 
its peak in leads I, aVL, V5, and V6, with QS or rS 
morphology in leads V1–V3, intrinsicoid deflection 
in leads V5, V6 of > 60 ms, and secondary ST-T 
changes opposite to the major QRS direction [10].
Response to CRT
Response to CRT was independently evalu-
ated using two parameters: NYHA class for SR and 
LVEF for ER. SR was defined as improvement in 
NYHA classification by ≥ 1 class [6, 8]. Improve-
ment in absolute LVEF ≥ 10% was defined as ER. 
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The clinical and echocardiographic follow-up was 
performed at least 6 months after implantation.
Statistical analysis
The statistical analysis was performed with 
IBM SPSS Statistics version 23. P values < 0.05 
were considered statistically significant. Normality 
of data distribution was tested with the Shapiro-
-Wilk test. Continuous variables were presented as 
mean ± standard deviation. Absolute frequency 
and percentages were reported for categorical 
data. The differences between paired variables 
were calculated with the appropriate Student 
t-test or Wilcoxon Signed Rank test according 
to normality of data distribution. Similarly, the 
differences between non-paired variables were 
calculated with the appropriate Student t-test or 
Mann-Whitney test according to normality. The c2 
test was performed for all categorical data. Odds 
ratios (OR) were reported with 95% confidence 
intervals (CI). The parameters tested as potential 
predictors of response to CRT included: QRS dura-
tion, QRS duration reduction, QRS axis and QRS 
axis change. All parameters were analyzed for SR 
and ER. Receiver operator characteristic (ROC) 
curves with particular cut-off points, specificity, 
and sensitivity were calculated for parameters with 
significant impact on the response.
Results
Patients
Among all patients who received CRT-D within 
the study period, 42 met the inclusion criteria. The 
average age at implantation was 66.4 ± 8.3 years, 
with predominance of men (54%). The mean follow-
up time was 29 ± 18.6 months. Baseline data for all 
patients including clinical parameters, preimplan-
tation ECG and echocardiographic measurements 
are shown in Table 1.
Mean QRS duration at baseline exceeded 160 ms. 
The majority of patients (73.8%) presented 
native QRS duration between 150 and 199 ms. 
Wider QRS complexes (≥ 200 ms) were found in 
9.5% of cases, while 16.7% of patients had QRS 
duration shorter than 150 ms, but not shorter than 
130 ms. After the implantation a reduction in mean 
QRS duration by 19.5 ± 23.0 ms was observed. 
In 21.4% of patients QRS duration increased or 
remained unchanged.
Patients with normal QRS axis and LAD ac-
counted for 95.3% of the study population. Detailed 
data on the distribution of QRS axis are presented 
in Table 1. Pre- and postimplantation mean QRS 
axis was –26.4 ± 41.7° and –47.9 ± 89.2°, respec-
tively, corresponding to a mean change of –21.5 
± 97.2°. The direction of the change was towards 
more negative values in 69% of patients and to-
wards more positive values in the remaining 31% 
of cases.
At follow-up a reduction in mean NYHA class 
(2.55 ± 0.48 vs. 2.02 ± 0.44; p < 0.001), improve-
ment in LVEF (26.7 ± 5.5 vs. 34.2 ± 10.3%; 
p < 0.001) and a reduction in QRS duration 
(164.0 ± 19.1 vs. 144.5 ± 25.4 ms; p < 0.001) were 
found. The numeric change in QRS axis was statis-
tically insignificant (–26.4 ± 41.7 vs. –47.9 ± 89.2°; 
p = 0.11).
Symptomatic response 
Symptomatic response was achieved in 16 
(38%) patients. The responders, in comparison 
with non-responders, had a significantly higher 
baseline NYHA class, lower NYHA class at follow-
Table 1. Patient baseline characteristics (n = 42).
Variable Value
Age [years] 66.4 ± 8.3
Sex:
Female 19 (45.2%)
Male 23 (54.8%)
Etiology:
Ischemic cardiomyopathy 31 (73.8%)
Non-ischemic cardiomyopathy 11 (26.2%)
Hypertension 28 (66.7%)
Diabetes mellitus 18 (42.9%)
Hyperlipidemia 10 (23.8%)
Obesity
NYHA class:
8 (19.0%)
II 13 (31.0%)
II/III 15 (35.7%)
III 12 (28.6%)
IV 1 (2.4%%)
LVEF [%] 26.7 ± 5.5
QRS duration [ms] 164.0 ± 19.1
QRS axis:
Normal 22 (52.4%)
LAD 18 (42.9%)
RAD 1 (2.4%)
EAD 1 (2.4%)
QRS axis [°] –26.4 ± 41.7
Data are presented as numbers and percentages or means ± 
standard deviations. EAD — extreme axis deviation; LAD — left 
axis deviation; LVEF — left ventricular ejection fraction; NYHA — 
New York Heart Association; RAD — right axis deviation
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up and wider QRS complex before and after implan-
tation (Table 2). The analysis of potential predictors 
of response to CRT revealed that patients with 
QRS < 150 ms before the procedure were less 
likely to respond well to CRT, while patients with 
QRS > 160 ms after the procedure had a greater 
chance to become responders to CRT (OR 7.2; 
95% CI 1.24–41.94). Longer QRS duration was 
associated with a better response, when measured 
before as well as after implantation of the device. 
ROC curves calculated for parameters found to be 
predictors of SR are presented in Figure 1. Area 
under the curve (AUC) for QRS duration before the 
procedure was 0.672 (95% CI 0.51–0.84; p = 0.037) 
with an optimal cut-off point of 178.5 ms (sensitiv-
ity 31.3%, specificity 84.6%). AUC calculated for 
postimplantation QRS duration was 0.727 (95% CI 
0.57–0.89; p = 0.005) with an optimal cut-off point 
of 157 ms (sensitivity 56.3%, specificity 73.1%). 
For postimplantation QRS axis, the AUC was 0.689 
(95% CI 0.53–0.85; p = 0.025), with a cut-off point 
of –60.5° yielding sensitivity of 62.5% and speci-
ficity of 61.5%. Shifting the cut-off point to –38.5° 
resulted in a sensitivity drop down to 50%, with 
a concomitant increase in specificity up to 76.9%.
Echocardiographic response 
Echocardiographic response was found in 19 
(45%) patients. The responders, in comparison 
with non-responders, had significantly lower LVEF 
values at baseline and substantially higher LVEF 
at follow-up (Table 3). The QRS axis before the 
procedure was significantly more negative among 
responders as compared with non-responders. 
Postimplantation QRS axis trended to be more 
negative among responders. More negative QRS 
axis before CRT was associated with a better ER in 
univariate analysis (Table 3). ROC curve was calcu-
lated for QRS axis before the procedure and AUC 
for this parameter was 0.693 (95% CI 0.54–0.85; 
p = 0.018) with an optimal cut-off point of –36° 
(sensitivity 63.2%, specificity 69.6%). 
Discussion
Cardiac resynchronization therapy remains 
the cornerstone of treatment for drug-refractory 
HF-rEF patients and wide QRS complex, particu-
larly those with LBBB. This single-center study 
aimed to assess the role of pre- and postimplanta-
tion ECG for prediction of long-term response 
to CRT in patients with HF-rEF and LBBB. The 
main finding of this study is that simple electro-
cardiographic patterns can predict the SR and ER 
to this therapy. However, the predictive value of 
electrocardiographic parameters in this setting 
seems to be moderate. In detail, the present 
research indicates that: 1) SR is determined by 
QRS duration, 2) preimplantation QRS duration 
of more than 150 ms, but less than 178.5 ms 
predicts SR, 3) ER is determined by the QRS 
axis, 4) this relation is insignificant for qualitative 
estimates of the QRS axis, however in quantita-
tive assessment preimplantation QRS axis of less 
than –36o predicts ER. 
The true target for CRT is the mechanical 
dyssynchrony of the LV and QRS duration is consid-
ered the primary sign of this condition. Prolonged 
QRS duration is related to disease severity and 
increased mortality in HF-rEF patients [11] and 
remains an important factor determining enroll-
ment for various studies assessing CRT. Based 
on large clinical trials and retrospective analyses 
[12–15], the current European Society of Cardiol-
ogy guidelines for CRT restricted the highest class 
of recommendations to patients with QRS duration 
of > 150 ms are considered to achieve the most 
favorable response [1]. However, even though QRS 
duration was recognized as an important indicator 
of CRT effectiveness, a significant percentage 
of patients receiving this treatment still fail to 
benefit despite widened QRS [5]. A more precise 
analysis of prolonged QRS duration as a response 
predictor is required, however the data is limited. 
Kronborg et al. [6] reported an increased rate of SR 
to CRT in patients with QRS duration between 150 
and 200 ms, compared with those with a shorter 
(< 150 ms) or longer QRS duration (> 200 ms). 
Sassone et al. [7] demonstrated that responsive-
ness to CRT in patients with LBBB decreases 
starting from QRS duration of around 180 ms on-
ward. In the present study, the upper cut-off value 
of QRS duration to predict non-responsiveness 
was 178.5 ms. These similar results confirm that 
there is a limit of mechanical dyssynchrony of LV, 
visually represented in ECG, above which CRT 
fails to provide significant benefit.
In contrast to literature data showing that 
the extent of QRS duration reduction after CRT 
implantation is a marker of subsequent response 
to CRT (the higher the reduction, the better the 
response), this study demonstrated a higher like-
lihood of response to CRT in patients with QRS 
duration > 160 ms on biventricular pacing (OR 
7.2, 95% CI 1.24–41.94). This unexpected finding 
perhaps might be explained by the fact that one of 
the response classifiers to be used in the present 
study was the NYHA classification — a method well 
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Table 2. Symptomatic response to CRT (NYHA class improvement ≥ 1): comparison of responders and 
non-responders, and electrocardiographic predictors of response to CRT in univariate analysis.
Variable Non-responders 
(n = 26)
Responders  
(n = 16)
P 
NYHA class at baseline 2.3 ± 0.31 2.9 ± 0.5 < 0.001 
NYHA class at follow-up 2.2 ± 0.3 1.8 ± 0.5 0.006 
LVEF preimplantation [%] 26.3 ± 5.5 27.5 ± 5.7 0.49
LVEF postimplantation [%] 32.7 ± 9.7 36.7 ± 11.0 0.22
QRS duration (preimplantation) [ms] 159.0 ± 18.3 172.3 ± 17.9 0.027
QRS duration (postimplantation) [ms] 136.7 ± 23.2 157.2 ± 24.1 0.009
QRS duration change [ms] (difference between  
post-implantation and preimplantation QRS duration)
–22.2 ± 21.2 –15.1 ± 25.8 0.33 
QRS axis (preimplantation) [°] –28.4 ± 43.4 –23.2 ± 40.0 0.7 
QRS axis (post-implantation) [°] –71.3 ± 76.8 –9.9 ± 97.0 0.028 
QRS axis change [°] (difference between  
postimplantation and preimplantation QRS axis)
–42.9 ± 93.8 13.3 ± 95.3 0.068
Variable OR 95% CI P
Electrocardiographic predictors of response to CRT
QRS duration (preimplantation)* [ms]
< 150 0.04 0.001–0.74 0.033
150–199  3.69 0.82–16.65 0.49
≥ 200  5.77 0.54–61.13 0.15
QRS duration (postimplantation)* [ms]
< 120 0.28 0.03–2.65 0.38
120–160 0.47  0.13–1.75 0.32
> 160 7.2  1.24–41.94 0.038
QRS duration (preimplantation) for a 1 ms increase 1.04 1.00–1.08 0.04 
QRS duration (postimplantation) for a 1 ms increase 1.04 1.01–1.07 0.02 
QRS axis (preimplantation)  
Normal 0.86 0.25–2.99 0.99
LAD 1.06 0.30–3.73 0.99
QRS axis (postimplantation)*
Normal 0.69  0.13–3.74 0.99
LAD 1.23 0.31–4.83 0.99
RAD 4.0  0.64–25.02 0.18
EAD 0.33 0.08–1.30 0.2
QRS axis (preimplantation) for a 1° increase 1.00 0.99–1.02 0.69
QRS axis (postimplantation) for a 1° increase 1.01 1.00–1.02 0.04
No QRS axis change 1.91 0.45–8.05 0.47
QRS duration reduction 0.71 0.16–3.16 0.71
QRS axis decrease 0.39 0.10–1.50 0.19
*Asterisk signifies that each category of the parameter was compared against all remaining categories joined together. CI — confidence inter-
val; CRT — cardiac resynchronization therapy; EAD — extreme axis deviation; LAD — left axis deviation; LVEF — left ventricular ejection  
fraction; NYHA — New York Heart Association Class; OR — odds ratio; RAD — right axis deviation
known for its subjectivity. Moreover, the majority 
of our patients (66.7%) presented with mild heart 
failure (NYHA class II), which is probably why the 
beneficial effect of CRT could be noticed primarily 
in patients with a high degree of underlying cardiac 
pathology and ventricular dyssynchrony as evi-
denced by largely widened QRS complexes, even 
on biventricular pacing. Unexpectedly, it was noted 
6 www.cardiologyjournal.org
Cardiology Journal XXXX, Vol. XX, No. X
that there was no statistical difference in pre- and 
post implantation QRS duration in echocardio-
graphic responders vs non-responders, however for 
symptomatic response assessment non-responders 
had significantly wider QRS duration, as expected. 
Possible explanations for this discrepancy might 
include a low number of participants enrolled in 
the study as well as a high percentage of patients 
with ischemic cardiomyopathy, with the latter be-
ing a risk factor of poorer resynchronization and 
response to CRT.
Previous studies provide consistent evidence 
of the importance of QRS duration in predicting 
response to CRT [2, 3, 6, 7, 12, 14, 15]. However, 
according to available research, only a few studies 
aimed to highlight the value of preimplantation 
QRS axis as a possible predictor of therapy success 
in LBBB patients, providing inconsistent results. 
In a study including 78 patients with LBBB receiv-
ing CRT, Garcia-Seara et al. [8] found that patients 
with LAD demonstrated a more favorable response 
(improvement in functional class, increase in LVEF 
of 5%, no hospital admissions for HF and remained 
alive throughout follow-up) than those with nor-
mal QRS axis. Also, Kronborg et al. [6] reported 
increased mortality and a lower likelihood of ER 
(improvement in absolute LVEF by 5%) in patients 
with RAD compared with normal axis or LAD. On 
the contrary, according to Brenyo et al. [16] the 
presence of LAD in LBBB is associated with less 
benefit from CRT. Similarly, Perotta et al. [17] sug-
gest that the presence of LAD or RAD is associated 
with a significant risk of worse response.
In the present study, no significant differences 
were seen in response to CRT with respect to the 
qualitative categorization of the QRS axis. How-
ever, this study takes an important subsequent step 
in examining the efficacy of CRT in the LBBB popu-
lation, relying on the quantitative value of QRS axis 
deviation. It was found that in a community-based 
cohort a more negative value of preimplantation 
QRS axis with a cut-off point of –36° was associated 
with a higher rate of response to CRT. Importantly, 
established herein was  a successful  cut-off point 
that distinguishes the predictive value of the QRS 
axis. It is believed that this finding is of particular 
interest, however further randomized controlled 
studies examining these conclusions with a greater 
number of patients in different environments are 
necessary.
Limitations of the study
The present study presents typical limitations 
of a retrospective single-center analysis. There-
fore, the  findings warrant confirmation in further 
larger prospective studies. Additionally, the inves-
tigated group was heterogeneous and there were 
different clinical and echocardiographic observers 
during the study period. It was not possible to de-
fine a specific point in time for the follow-up due 
to retrospective character of the study and lack of 
routinely scheduled long-term echocardiography 
examinations in patients treated with CRT. Thus, 
only patients with echocardiographic examination 
performed at least 6 months after the device im-
plantation were included as this is the minimum 
period to observe changes in ejection fraction due 
to LV remodeling. Another major limitation is the 
small study group, which potentially exposed the 
results to type II error. Furthermore, due to a lim-
ited sample size the present study did not evaluate 
other causes for the lack of response to CRT, not 
associated with pacing, and multivariate analysis 
was not performed. There was also an inability to 
perform sub-analyses of the main study results. 
Only 2 patients in this study had axis other than 
normal or left deviated (one had RAD and one had 
EAD). However, the proportion of RAD patients 
in the present group (2.4%) is comparable to data 
presented in the literature (e.g. Kronborg et al. 
[6] reported 4% patients with RAD and LBBB). 
Finally, lower rates of responders to CRT were 
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Figure 1. Receiver operator characteristic curves for 
predictors of symptomatic response to cardiac resyn-
chronization therapy: preimplantation QRS duration 
(AUC 0.672 [95% CI 0.51–0.84]; p = 0.037), postimplan-
tation QRS duration (AUC 0.727 [95% CI 0.57–0.89]; 
p = 0.005) and postimplantation QRS axis (AUC 0.689 
[95% CI 0.53–0.85]; p = 0.025).
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reported when compared with other studies. This 
fact may have been caused by a high prevalence of 
established factors associated with poor response 
to CRT in the present study participants (i.e. is-
chemic etiology of HF-rEF, male patients and lower 
severity of symptoms).
Table 3. Echocardiographic response to CRT (absolute LVEF increased by ≥ 10%): comparison of re-
sponders and non-responders, and electrocardiographic predictors of response to CRT in univariate 
analysis.
Non-responders  
(n = 23)
Responders  
(n = 19)
P 
NYHA class at baseline 2.54 ± 0.54 2.55 ± 0.4 0.7
NYHA class at follow-up 2.02 ± 0.53 2.03 ± 0.31 0.94
LVEF preimplantation [%] 28.5 ± 5.0 24.6 ± 5.5 0.02
LVEF postimplantation [%] 27.8 ± 6.0 42.1 ± 8.8 < 0.001
QRS duration (preimplantation) [ms] 161.0 ± 20.3 167.6 ± 17.3 0.27
QRS duration (postimplantation) [ms] 142.8 ± 25.1 146.6 ± 26.2 0.63
QRS duration change [ms] (difference between  
postimplantation and preimplantation QRS duration)
–18.3 ± 25.4 –21.0 ± 20.4 0.71
QRS axis (preimplantation) [°] –13.1 ± 34.7 –42.6 ± 44.6 0.021
QRS axis (postimplantation) [°] –27.0 ± 98.1 –73.3 ± 71.4 0.09
QRS axis change [°] (difference between  
postimplantation and preimplantation QRS axis)
–13.9 ± 105.4 –30.7 ± 88.3 0.58
Variable OR 95% CI P
Electrocardiographic predictors of response to CRT
QRS duration (preimplantation)* [ms]
< 150 0.42 0.07–2.46 0.43
150–199 1.64 0.40–6.76 0.73
≥ 200 1.24 0.16–9.75 0.99
QRS duration (postimplantation)* [ms]
< 120 0.56 0.09–3.45 0.67
120–160 0.75 0.21–2.72 0.75
> 160 2.38 0.49–11.62 0.43
QRS duration (preimplantation) for a 1 ms increase 1.019 0.99–1.05 0.27
QRS duration (postimplantation) for a 1 ms increase 1.01 0.98–1.03 0.62
QRS axis (preimplantation)
Normal 0.31 0.09–1.10 0.12
LAD 2.08 0.60–7.22 0.35
QRS axis (postimplantation)*
Normal 0.89 0.17–4.58 0.99
LAD 1.31 0.34–5.01 0.74
RAD 0.20 0.02–1.89 0.2
EAD 1.69 0.49–5.86 0.53
QRS axis (preimplantation) for a 1° increase 0.98 0.96–1.00 0.03
QRS axis (postimplantation) for a 1° increase 0.997 0.99–1.004 0.40
No axis change 1.29 0.31–5.35 0.99
QRS duration reduction 1.04 0.24–4.58 0.99
QRS axis decrease 1.49 0.39–5.66 0.74
*Asterisk signifies that each category of the parameter was compared against all remaining categories joined together. CI — confidence inter-
val; CRT — cardiac resynchronization therapy; EAD — extreme axis deviation; LAD — left axis deviation; LVEF — left ventricular ejection frac-
tion; NYHA — New York Heart Association Class; OR — odds ratio; RAD — right axis deviation; N — number of patients
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Conclusions
The present study indicates that marked QRS 
prolongation in pre- and postimplantation assess-
ment and preimplantation negative deviation of 
the QRS axis are moderate predictors of response 
to CRT in chronic heart failure patients with low 
LVEF and LBBB. In detail, substantial pre- and 
postimplantation QRS prolongation is associated 
with SR, while more negative pre-implantation 
QRS axis seems to predict echocardiographic 
response.
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